PMID: 2114309Jun 4, 1990Paper

Synergism of type I and type II interferons in stimulating the activity of the same DNA enhancer

FEBS Letters
D VaimanJ Chebath

Abstract

Type I and type II interferons (IFNs) can act synergistically to activate the transcription of the 2-5A synthetase gene. We used in vivo functional assays of sequences from the gene promoter region to determine which DNA segment mediates the gene induction by IFN gamma and the synergistic effect. We found that the type I IFN-inducible enhancer (or IRS) of the 2-5A synthetase gene also confers inducibility by type II IFN to a reporter CAT gene, though the time course and dose response of the induction by the two IFNs are quite different. A clear synergism of the two IFN in stimulating the IRS is observed at low doses of the two IFNs.

References

Oct 1, 1979·Infection and Immunity·W R FleischmannH M Johnson
Jan 1, 1987·Annual Review of Biochemistry·S PestkaC E Samuel
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L E ReidI M Kerr
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T C DaleG R Stark
May 1, 1987·Journal of Virology·J KusariG C Sen
Jan 1, 1987·Molecular and Cellular Biology·J Kusari, G C Sen
Jan 1, 1982·Annual Review of Biochemistry·P Lengyel
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D DiMaioT Maniatis
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.